J. Day

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity

A. Worth, S. Burns, Martin Campbell, 2022, Journal of Clinical Immunology.

Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

M. Singer, K. Ardeshna, A. Khwaja, 2020, British journal of haematology.

Interleukin‐1 blockade with anakinra in acute leukaemia patients with severe COVID‐19 pneumonia appears safe and may result in clinical improvement

P. Kottaridis, T. Fox, B. Carpenter, 2020, British journal of haematology.

Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood

A. Laurence, P. Veys, A. Worth, 2022, Journal of Clinical Immunology.